[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 US HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

October 2018 | 60 pages | ID: U184E7079D1EN
Venture Planning Group

US$ 900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Blood Banks
  • Public Health Labs
  • Physician OfficesThe DataPack provides sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche.

    Contains 60 pages and 7 tables
  • Major Companies Developing or Marketing AIDS Tests
    USA: HIV or HIV1/2/Comb      Test Volume and Sales Forecast by Market Segment
    USA: HIV Ag Test Volume and Sales Forecast by Market Segment
    USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
    USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
    USA: AIDS Diagnostics Market by Major Supplier
    USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers


    More Publications